Burning Rock Biotech Limited (BNR) Comparison with companies in other sectors?

Burning Rock Biotech Limited has a share price of 1.08M. You can analyze Burning Rock Biotech Limited (BNR) competitors across different market sectors through stock heatmaps.

What are BNR's NET and operating margins?

Burning Rock Biotech Limited (BNR) operating margin is around -0.47, and net profit margin is approximately -0.46 as of the latest reports.

In what way does BNR's earnings per share (EPS) trend reflect its financial momentum?

Burning Rock Biotech Limited (BNR) EPS is -3.22 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Burning Rock Biotech Limited is -2.11, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Burning Rock Biotech Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Burning Rock Biotech Limited like P/E which is -0.22, P/B which is 0.09, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Burning Rock Biotech Limited

BNR•NASDAQ

Healthcare

Medical - Diagnostics & Research

$6.80

$-1.57(-18.76%)

Fundamental Analysis of Burning Rock Biotech Limited (BNR)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-3.22

P/E Ratio

-2.11

ROE

-0.39%

Net Margin

-0.46%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$7.32M

Shares OutstandingTotal number of shares issued

$1.08M

Book Value/ShareNet worth per share

$53.13

Revenue/ShareAnnual revenue per share

$48.62

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-3.22

Net MarginNet income as percentage of revenue

-45.59%

Operating MarginOperating income as percentage of revenue

-47.18%

ROEReturn on shareholders' equity

-38.50%

ROAReturn on total assets

-27.91%

ROCEReturn on capital employed

-41.00%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-9.13

Cash/ShareCash and equivalents per share

$46.009

FCF YieldFree cash flow as percentage of market cap

-188.60%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for BNRFinancial Ratios Analysis details for BNR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for BNRSector Benchmarking details for BNR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Burning Rock Biotech Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Burning Rock Biotech Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Burning Rock Biotech Limited's unique business strengths and challenges.

Key Financial Metrics for Burning Rock Biotech Limited

For Burning Rock Biotech Limited, essential financial indicators include EPS -3.22, PE -2.11, and ROE -0.39. These key ratios reveal insights into Burning Rock Biotech Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Burning Rock Biotech Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Burning Rock Biotech Limited

Metrics like Net Margin -45.59% and ROA -27.91% shed light on how well Burning Rock Biotech Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Burning Rock Biotech Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Burning Rock Biotech Limited

Using ratios such as P/B Ratio 0.09 and PEG Ratio -0.00, investors can assess whether Burning Rock Biotech Limited is appropriately valued based on its financials and growth potential. These figures, combined with Burning Rock Biotech Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Burning Rock Biotech Limited

Financial health indicators, such as Debt/Equity Ratio 0.07 and Cash Flow $-9.13, provide a snapshot of Burning Rock Biotech Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Burning Rock Biotech Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Burning Rock Biotech Limited

Investing in Burning Rock Biotech Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Burning Rock Biotech Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;